APO Research
Talk to an analyst

APO RESEARCH · REPORT

Over the Counter (OTC) Drugs & Dietary Supplements

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Over the Counter (OTC) Drugs & Dietary Supplements Industry Growth and Trends Forecast to 2032

20 December 2025123 pages

Choose your research edition.

Industry ResearchOver the Counter (OTC) Drugs & Dietary Supplements Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Over the Counter (OTC) Drugs & Dietary Supplements Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Over the Counter (OTC) Drugs & Dietary Supplements Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Over the Counter (OTC) Drugs & Dietary Supplements Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Over the Counter (OTC) Drugs & Dietary Supplements Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

According to APO Research, the global Over the Counter (OTC) Drugs & Dietary Supplements market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Over the Counter (OTC) Drugs & Dietary Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Over the Counter (OTC) Drugs & Dietary Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Over the Counter (OTC) Drugs & Dietary Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Over the Counter (OTC) Drugs & Dietary Supplements market include Sanofi S.A, Johnson & Johnson, Novartis International AG, Merck & Co., Inc., Roche Holding AG, Pfizer Inc., GlaxoSmithKline plc., Bayer Healthcare AG and AbbVie Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Over the Counter (OTC) Drugs & Dietary Supplements market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Over the Counter (OTC) Drugs & Dietary Supplements market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Over the Counter (OTC) Drugs & Dietary Supplements market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Over the Counter (OTC) Drugs & Dietary Supplements.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Over the Counter (OTC) Drugs & Dietary Supplements market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Over the Counter (OTC) Drugs & Dietary Supplements Market by Company

Sanofi S.A

Johnson & Johnson

Novartis International AG

Merck & Co., Inc.

Roche Holding AG

Pfizer Inc.

GlaxoSmithKline plc.

Bayer Healthcare AG

AbbVie Inc.

AstraZeneca plc.

The Colgate-Palmolive Company

Reckitt Benckiser Plc.

Gilead Sciences

Bausch & Lomb

Alliance Healthcare

Allergan, Plc.

Alkalon A/S

Alfresa Pharma Corporation

Alcon Inc.

Alacer Corp.

Over the Counter (OTC) Drugs & Dietary Supplements Segment by Type

Cough, Cold, and Flu Products

Mineral Supplements

Dermatological Products

Vitamin Supplements

Ophthalmic Products

Analgesic & Pain Relievers

Over the Counter (OTC) Drugs & Dietary Supplements Segment by Application

Retail Pharmacies

Online Pharmacy

Hospital Pharmacies

Others

Over the Counter (OTC) Drugs & Dietary Supplements Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Over the Counter (OTC) Drugs & Dietary Supplements market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Over the Counter (OTC) Drugs & Dietary Supplements and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Over the Counter (OTC) Drugs & Dietary Supplements.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Over the Counter (OTC) Drugs & Dietary Supplements companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Region (2021-2026) Table 4. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Region (2027-2032) Table 6. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Share by Type (2021-2026) Table 9. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Share Forecasted by Type (2027-2032) Table 11. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Share by Application (2021-2026) Table 24. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Share Forecasted by Application (2027-2032) Table 26. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Over the Counter (OTC) Drugs & Dietary Supplements Industry Trends Table 37. Over the Counter (OTC) Drugs & Dietary Supplements Industry Drivers Table 38. Over the Counter (OTC) Drugs & Dietary Supplements Industry Opportunities and Challenges Table 39. Over the Counter (OTC) Drugs & Dietary Supplements Industry Restraints Table 40. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Company (2021-2026) Table 42. Global Over the Counter (OTC) Drugs & Dietary Supplements Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Over the Counter (OTC) Drugs & Dietary Supplements Key Company Headquarters & Area Served Table 44. Global Over the Counter (OTC) Drugs & Dietary Supplements Company, Product Type & Application Table 45. Global Over the Counter (OTC) Drugs & Dietary Supplements Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Over the Counter (OTC) Drugs & Dietary Supplements by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Sanofi S.A Company Information Table 49. Sanofi S.A Business Overview Table 50. Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 52. Sanofi S.A Recent Development Table 53. Johnson & Johnson Company Information Table 54. Johnson & Johnson Business Overview Table 55. Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 57. Johnson & Johnson Recent Development Table 58. Novartis International AG Company Information Table 59. Novartis International AG Business Overview Table 60. Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 62. Novartis International AG Recent Development Table 63. Merck & Co., Inc. Company Information Table 64. Merck & Co., Inc. Business Overview Table 65. Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 67. Merck & Co., Inc. Recent Development Table 68. Roche Holding AG Company Information Table 69. Roche Holding AG Business Overview Table 70. Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 72. Roche Holding AG Recent Development Table 73. Pfizer Inc. Company Information Table 74. Pfizer Inc. Business Overview Table 75. Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 77. Pfizer Inc. Recent Development Table 78. GlaxoSmithKline plc. Company Information Table 79. GlaxoSmithKline plc. Business Overview Table 80. GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 82. GlaxoSmithKline plc. Recent Development Table 83. Bayer Healthcare AG Company Information Table 84. Bayer Healthcare AG Business Overview Table 85. Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 87. Bayer Healthcare AG Recent Development Table 88. AbbVie Inc. Company Information Table 89. AbbVie Inc. Business Overview Table 90. AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 92. AbbVie Inc. Recent Development Table 93. AstraZeneca plc. Company Information Table 94. AstraZeneca plc. Business Overview Table 95. AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 97. AstraZeneca plc. Recent Development Table 98. The Colgate-Palmolive Company Company Information Table 99. The Colgate-Palmolive Company Business Overview Table 100. The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 102. The Colgate-Palmolive Company Recent Development Table 103. Reckitt Benckiser Plc. Company Information Table 104. Reckitt Benckiser Plc. Business Overview Table 105. Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 107. Reckitt Benckiser Plc. Recent Development Table 108. Gilead Sciences Company Information Table 109. Gilead Sciences Business Overview Table 110. Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 112. Gilead Sciences Recent Development Table 113. Bausch & Lomb Company Information Table 114. Bausch & Lomb Business Overview Table 115. Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 117. Bausch & Lomb Recent Development Table 118. Alliance Healthcare Company Information Table 119. Alliance Healthcare Business Overview Table 120. Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 122. Alliance Healthcare Recent Development Table 123. Allergan, Plc. Company Information Table 124. Allergan, Plc. Business Overview Table 125. Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 127. Allergan, Plc. Recent Development Table 128. Alkalon A/S Company Information Table 129. Alkalon A/S Business Overview Table 130. Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 132. Alkalon A/S Recent Development Table 133. Alfresa Pharma Corporation Company Information Table 134. Alfresa Pharma Corporation Business Overview Table 135. Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 137. Alfresa Pharma Corporation Recent Development Table 138. Alcon Inc. Company Information Table 139. Alcon Inc. Business Overview Table 140. Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 142. Alcon Inc. Recent Development Table 143. Alacer Corp. Company Information Table 144. Alacer Corp. Business Overview Table 145. Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 147. Alacer Corp. Recent Development Table 148. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2021-2026) & (US$ Million) Table 150. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Country (2021-2026) Table 151. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Share Forecast by Country (2027-2032) Table 153. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2021-2026) & (US$ Million) Table 155. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Country (2021-2026) Table 156. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Share Forecast by Country (2027-2032) Table 158. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2021-2026) & (US$ Million) Table 160. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Country (2021-2026) Table 161. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Share Forecast by Country (2027-2032) Table 163. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2021-2026) & (US$ Million) Table 165. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Country (2021-2026) Table 166. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Share Forecast by Country (2027-2032) Table 168. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2021-2026) & (US$ Million) Table 170. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Country (2021-2026) Table 171. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Share Forecast by Country (2027-2032) Table 173. Research Programs/Design for This Report Table 174. Authors List of This Report Table 175. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Over the Counter (OTC) Drugs & Dietary Supplements Product Image Figure 3. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2021-2032) & (US$ Million) Figure 5. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Region: 2025 VS 2032 Figure 6. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Region (2021-2032) Figure 7. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Cough, Cold, and Flu Products Image Figure 13. Global Cough, Cold, and Flu Products Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Mineral Supplements Image Figure 15. Global Mineral Supplements Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Dermatological Products Image Figure 17. Global Dermatological Products Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Vitamin Supplements Image Figure 19. Global Vitamin Supplements Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Ophthalmic Products Image Figure 21. Global Ophthalmic Products Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Analgesic & Pain Relievers Image Figure 23. Global Analgesic & Pain Relievers Market Size YoY Growth (2021-2032) & (US$ Million) Figure 24. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Overview by Type (2021-2032) & (US$ Million) Figure 25. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type 2025 VS 2032 Figure 26. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size Share by Type (2021-2032) Figure 27. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size Share by Type (2021-2032) Figure 28. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size Share by Type (2021-2032) Figure 29. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size Share by Type (2021-2032) Figure 30. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size Share by Type (2021-2032) Figure 31. Retail Pharmacies Image Figure 32. Global Retail Pharmacies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Online Pharmacy Image Figure 34. Global Online Pharmacy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Hospital Pharmacies Image Figure 36. Global Hospital Pharmacies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Others Image Figure 38. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application 2025 VS 2032 Figure 41. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size Share by Application (2021-2032) Figure 42. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size Share by Application (2021-2032) Figure 43. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size Share by Application (2021-2032) Figure 44. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size Share by Application (2021-2032) Figure 45. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size Share by Application (2021-2032) Figure 46. Global Top 5 and 10 Over the Counter (OTC) Drugs & Dietary Supplements Players Market Share by Revenue in 2025 Figure 47. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 48. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Country (2021-2032) Figure 51. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Country (2021-2032) Figure 54. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Country (2021-2032) Figure 57. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Country (2021-2032) Figure 60. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Country: 2021 VS 2025 VS 2032 Figure 62. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Country (2021-2032) Figure 63. Years Considered Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Cough, Cold, and Flu Products
  • Mineral Supplements
  • Dermatological Products
  • Vitamin Supplements
  • Ophthalmic Products
  • Analgesic & Pain Relievers
Applications
  • Retail Pharmacies
  • Online Pharmacy
  • Hospital Pharmacies
  • Others
Companies covered
  • Sanofi S.A
  • Johnson & Johnson
  • Novartis International AG
  • Merck & Co., Inc.
  • Roche Holding AG
  • Pfizer Inc.
  • GlaxoSmithKline plc.
  • Bayer Healthcare AG
  • AbbVie Inc.
  • AstraZeneca plc.
  • The Colgate-Palmolive Company
  • Reckitt Benckiser Plc.
  • Gilead Sciences
  • Bausch & Lomb
  • Alliance Healthcare
  • Allergan, Plc.
  • Alkalon A/S
  • Alfresa Pharma Corporation
  • Alcon Inc.
  • Alacer Corp.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2021-2032)
  5. 1.4.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2021-2026)
  6. 1.4.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2027-2032)
  7. 1.5 Key Regions Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2021-2032)
  8. 1.5.1 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate (2021-2032)
2 Over the Counter (OTC) Drugs & Dietary Supplements Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Cough, Cold, and Flu Products
  3. 2.1.2 Mineral Supplements
  4. 2.1.3 Dermatological Products
  5. 2.1.4 Vitamin Supplements
  6. 2.1.5 Ophthalmic Products
  7. 2.1.6 Analgesic & Pain Relievers
  8. 2.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type
  9. 2.2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Overview by Type (2021-2032)
  10. 2.2.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Historic Market Size Review by Type (2021-2026)
  11. 2.2.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecasted by Type (2027-2032)
  12. 2.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Regions
  13. 2.3.1 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size Breakdown by Type (2021-2026)
  14. 2.3.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size Breakdown by Type (2021-2026)
  15. 2.3.3 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size Breakdown by Type (2021-2026)
  16. 2.3.4 South America Over the Counter (OTC) Drugs & Dietary Supplements Market Size Breakdown by Type (2021-2026)
  17. 2.3.5 Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size Breakdown by Type (2021-2026)
3 Over the Counter (OTC) Drugs & Dietary Supplements Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Retail Pharmacies
  3. 3.1.2 Online Pharmacy
  4. 3.1.3 Hospital Pharmacies
  5. 3.1.4 Others
  6. 3.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application
  7. 3.2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Regions
  11. 3.3.1 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Over the Counter (OTC) Drugs & Dietary Supplements Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Over the Counter (OTC) Drugs & Dietary Supplements Industry Trends
  2. 4.2 Over the Counter (OTC) Drugs & Dietary Supplements Industry Drivers
  3. 4.3 Over the Counter (OTC) Drugs & Dietary Supplements Industry Opportunities and Challenges
  4. 4.4 Over the Counter (OTC) Drugs & Dietary Supplements Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Over the Counter (OTC) Drugs & Dietary Supplements Revenue (2021-2026)
  2. 5.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Key Company Headquarters & Area Served
  4. 5.4 Global Over the Counter (OTC) Drugs & Dietary Supplements Company, Product Type & Application
  5. 5.5 Global Over the Counter (OTC) Drugs & Dietary Supplements Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Over the Counter (OTC) Drugs & Dietary Supplements Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Over the Counter (OTC) Drugs & Dietary Supplements Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Sanofi S.A
  2. 6.1.1 Sanofi S.A Company Information
  3. 6.1.2 Sanofi S.A Business Overview
  4. 6.1.3 Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  6. 6.1.5 Sanofi S.A Recent Developments
  7. 6.2 Johnson & Johnson
  8. 6.2.1 Johnson & Johnson Company Information
  9. 6.2.2 Johnson & Johnson Business Overview
  10. 6.2.3 Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  12. 6.2.5 Johnson & Johnson Recent Developments
  13. 6.3 Novartis International AG
  14. 6.3.1 Novartis International AG Company Information
  15. 6.3.2 Novartis International AG Business Overview
  16. 6.3.3 Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  18. 6.3.5 Novartis International AG Recent Developments
  19. 6.4 Merck & Co., Inc.
  20. 6.4.1 Merck & Co., Inc. Company Information
  21. 6.4.2 Merck & Co., Inc. Business Overview
  22. 6.4.3 Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  24. 6.4.5 Merck & Co., Inc. Recent Developments
  25. 6.5 Roche Holding AG
  26. 6.5.1 Roche Holding AG Company Information
  27. 6.5.2 Roche Holding AG Business Overview
  28. 6.5.3 Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  30. 6.5.5 Roche Holding AG Recent Developments
  31. 6.6 Pfizer Inc.
  32. 6.6.1 Pfizer Inc. Company Information
  33. 6.6.2 Pfizer Inc. Business Overview
  34. 6.6.3 Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  36. 6.6.5 Pfizer Inc. Recent Developments
  37. 6.7 GlaxoSmithKline plc.
  38. 6.7.1 GlaxoSmithKline plc. Company Information
  39. 6.7.2 GlaxoSmithKline plc. Business Overview
  40. 6.7.3 GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  42. 6.7.5 GlaxoSmithKline plc. Recent Developments
  43. 6.8 Bayer Healthcare AG
  44. 6.8.1 Bayer Healthcare AG Company Information
  45. 6.8.2 Bayer Healthcare AG Business Overview
  46. 6.8.3 Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  48. 6.8.5 Bayer Healthcare AG Recent Developments
  49. 6.9 AbbVie Inc.
  50. 6.9.1 AbbVie Inc. Company Information
  51. 6.9.2 AbbVie Inc. Business Overview
  52. 6.9.3 AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  54. 6.9.5 AbbVie Inc. Recent Developments
  55. 6.10 AstraZeneca plc.
  56. 6.10.1 AstraZeneca plc. Company Information
  57. 6.10.2 AstraZeneca plc. Business Overview
  58. 6.10.3 AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  60. 6.10.5 AstraZeneca plc. Recent Developments
  61. 6.11 The Colgate-Palmolive Company
  62. 6.11.1 The Colgate-Palmolive Company Company Information
  63. 6.11.2 The Colgate-Palmolive Company Business Overview
  64. 6.11.3 The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  66. 6.11.5 The Colgate-Palmolive Company Recent Developments
  67. 6.12 Reckitt Benckiser Plc.
  68. 6.12.1 Reckitt Benckiser Plc. Company Information
  69. 6.12.2 Reckitt Benckiser Plc. Business Overview
  70. 6.12.3 Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  72. 6.12.5 Reckitt Benckiser Plc. Recent Developments
  73. 6.13 Gilead Sciences
  74. 6.13.1 Gilead Sciences Company Information
  75. 6.13.2 Gilead Sciences Business Overview
  76. 6.13.3 Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  78. 6.13.5 Gilead Sciences Recent Developments
  79. 6.14 Bausch & Lomb
  80. 6.14.1 Bausch & Lomb Company Information
  81. 6.14.2 Bausch & Lomb Business Overview
  82. 6.14.3 Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  84. 6.14.5 Bausch & Lomb Recent Developments
  85. 6.15 Alliance Healthcare
  86. 6.15.1 Alliance Healthcare Company Information
  87. 6.15.2 Alliance Healthcare Business Overview
  88. 6.15.3 Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  90. 6.15.5 Alliance Healthcare Recent Developments
  91. 6.16 Allergan, Plc.
  92. 6.16.1 Allergan, Plc. Company Information
  93. 6.16.2 Allergan, Plc. Business Overview
  94. 6.16.3 Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  96. 6.16.5 Allergan, Plc. Recent Developments
  97. 6.17 Alkalon A/S
  98. 6.17.1 Alkalon A/S Company Information
  99. 6.17.2 Alkalon A/S Business Overview
  100. 6.17.3 Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  102. 6.17.5 Alkalon A/S Recent Developments
  103. 6.18 Alfresa Pharma Corporation
  104. 6.18.1 Alfresa Pharma Corporation Company Information
  105. 6.18.2 Alfresa Pharma Corporation Business Overview
  106. 6.18.3 Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  108. 6.18.5 Alfresa Pharma Corporation Recent Developments
  109. 6.19 Alcon Inc.
  110. 6.19.1 Alcon Inc. Company Information
  111. 6.19.2 Alcon Inc. Business Overview
  112. 6.19.3 Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  114. 6.19.5 Alcon Inc. Recent Developments
  115. 6.20 Alacer Corp.
  116. 6.20.1 Alacer Corp. Company Information
  117. 6.20.2 Alacer Corp. Business Overview
  118. 6.20.3 Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  120. 6.20.5 Alacer Corp. Recent Developments
7 North America
  1. 7.1 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2021-2026)
  3. 7.3 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2021-2026)
  3. 8.3 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2021-2026)
  3. 10.3 South America Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst